相关实验视频
Updated: Jan 18, 2026
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.7K
一个共价ACE2诱受体的理性设计,它可以广泛中和SARS-CoV-2变体
Nobumasa Hino1,2,3, Risa Takada1, Kyosuke Suzuki1,2
1Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
Protein science : a publication of the Protein Society
|September 13, 2025
概括
科学家们开发了一种新的共价诱受体来对抗SARS-CoV-2变种. 这种策略通过向保护区域来有效中和病毒,提供强大,广泛的抗病毒方法来应对不断变化的威胁.
科学领域:
- 病毒学 病毒学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 的演变需要新的抗病毒策略.
- 协同结合增强了治疗蛋白质的有效性,但可以受到病毒突变的阻碍.
- 现有的疫苗和疗法面临着新出现的SARS-CoV-2变种带来的挑战.
研究的目的:
- 开发一种对抗SARS-CoV-2的广泛中和的共价血管酶转化酶2-Fc (ACE2-Fc) 诱.
- 利用合理的设计,整合功能基因组学和结构信息.
- 针对病毒受体结合域 (RBD) 上的保存残留物,以提高疗效.
主要方法:
- 通过非正规氨基酸-硫酸-L-氨酸 (FSY) 进行工程 ACE2-Fc 构造.
- 在SARS-CoV-2 RBD上向的氨酸473 (Y473) 用于共价键的形成.
- 对野生型和Omicron BA.5变种进行了对抗测试的共价ACE2-Fc构造 (E23FSY,T27FSY).
主要成果:
- 工程结构在RBD上与Y473形成了特定的共价键.
- 同价捕获仍然有效地对抗Omicron BA.5 RBD.
- 在伪病毒试验中,E23FSY和T27FSY显示对D614G和Omicron变异的强效增强.
结论:
- 用共价诱针对病毒RBD上的进化约束的残留物是有效的.
- 这一策略产生了强效的,广泛的共价抑制剂,可以对抗像SARS-CoV-2这样快速演变的病毒.
- 开发的共价性ACE2-Fc诱为对抗病毒逃生变体提供了有希望的方法.
更多相关视频
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
5.2K
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.7K
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
02:50Conjugated Proteins
27.5K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
27.5K